HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DUALITYBIO-B

204.600

-21.000-9.31%

Volume:1.71M

Turnover:364.95M

Market Cap:18.51B

PE:-4.44

High:235.000

Open:235.000

Low:202.000

Close:225.600

52wk High:563.500

52wk Low:188.100

Shares:90.48M

HK Float Shares:90.48M

Volume Ratio:1.87

T/O Rate:1.89%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-46.117

ROE:-1282.14%

ROA:-9.61%

PB:6.58

PE(LYR):-4.44

PS:8.63

Loading ...

Overview Company News Filings

Movement Alert｜Duality Biotherapeutics-B Falls 5.59% in Regular Trading, Continued Correction From Highs Despite Recent Positive Catalysts

Movement Alert｜Duality Biotherapeutics-B Rises 5.16% in Regular Trading, ASCO Annual Meeting Opens as ADC Pipeline Advances Boost Sector Sentiment

DualityBio trims outstanding shares via HKD 10.18 million buy-back; issues 21,000 new shares from Pre-IPO options

Bulletin Express

DualityBio-B (09606) Spends HK$10.18 Million on Share Buyback on May 28

Duality Biotherapeutics files HKEX next-day disclosure return, repurchase at HKD 212.88/share

Movement Alert｜Duality Biotherapeutics-B Falls 5.38% in Regular Trading, Trading at 210.8 HKD

DUALITYBIO-B Surges Over 5% on Global Phase III Trial Milestone for B7-H3 ADC with BioNTech

Movement Alert｜Duality Biotherapeutics-B Rises 5.36% in Regular Trading, Buyback Execution and Institutional Accumulation Boost Confidence

DUALITYBIO-B (09606) Spends HK$6.5144 Million on Share Buyback

LAV Asset Management Boosts Stake in DUALITYBIO-B with 105,000 Share Purchase

Duality Biotherapeutics Launches $40 Million Stock Buyback; Shares Rise 3%

MT Newswires Live

DualityBio-B Surges Nearly 5% in Morning Trading, Announces Up to $40 Million Share Buyback Plan

Movement Alert｜Duality Biotherapeutics Rises 5.66% in Regular Trading, Share Buyback Plan Triggers Rebound After Multi-Day Selloff

DUALITYBIO-B (09606) Announces Up to $40 Million Share Buyback, Founder Plans Additional $5 Million Purchase

Duality Biotherapeutics Inc - Announces Share Repurchase Plan of up to $40 Mln

THOMSON REUTERS

DUALITYBIO-B Exercises Option for U.S. Cost and Profit/Loss Sharing on DB-1311/BNT324

Duality Biotherapeutics Exercises U.S. Cost- and Profit-Sharing Option for ADC Candidate DB-1311/BNT324 in Collaboration with BioNTech

Bulletin Express

HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%

Tiger Newspress

DualityBio-B Adds 0.19 Million New Shares in April; Public Float Remains Compliant

Bulletin Express

Duality Biotherapeutics shareholders approved RMB share issue plan at EGM

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/09606/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"09606","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","market":"HK","secType":"STK","nameCN":"DUALITYBIO-B","latestPrice":204.6,"timestamp":1780301307007,"preClose":225.6,"halted":0,"volume":1710564,"delay":0,"changeRate":-0.09308510638297872,"floatShares":90475600,"shares":90475600,"eps":-46.11737613945431,"marketStatus":"Not Yet Opened","change":-21,"latestTime":"06-01 16:08:27","open":235,"high":235,"low":202,"amount":364953557,"amplitude":0.146277,"askPrice":204.8,"askSize":100,"bidPrice":204.6,"bidSize":2200,"shortable":3,"etf":0,"ttmEps":-36.930980208962005,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1780363800000},"marketStatusCode":0,"adr":0,"listingDate":1744646400000,"exchange":"SEHK","adjPreClose":225.6,"openAndCloseTimeList":[[1780277400000,1780286400000],[1780290000000,1780300800000]],"volumeRatio":1.872144,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09606\",,,,,undefined,":{"symbol":"09606","floatShares":90475600,"roa":"-9.61%","roe":"-1282.14%","lyrEps":-46.117376,"volumeRatio":1.872144,"shares":90475600,"dividePrice":0,"high":235,"amplitude":0.146277,"preClose":225.6,"low":202,"week52Low":188.1,"pbRate":"6.58","psRate":"8.63","week52High":563.5,"institutionHeld":0,"latestPrice":204.6,"committee":0.913043,"eps":-46.11737613945431,"divideRate":0,"volume":1710564,"delay":0,"ttmEps":-36.930980208962005,"open":235,"prevYearClose":298.2,"prevWeekClose":225.6,"prevMonthClose":225.6,"prevQuarterClose":295,"fiveDayClose":222.8,"twentyDayClose":276,"sixtyDayClose":299},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09606\",params:#limit:5,,,undefined,":[{"date":"2026-03-23","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-26","symbol":"09606","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09606\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09606\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1761408000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09606\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09606","date":"2026-05-29","current":-5.540064,"percent":0.974545,"low":-29.984477,"twenty":-18.096065,"median":-9.620334,"eighty":-8.669056,"high":-6.033707,"avg":-12.91758,"sd":6.15558,"marketCap":20400514838},"quantilePoints":[{"date":"2025-04-17","current":-14.905978,"twenty":-15.065639,"median":-14.442293,"eighty":-11.334487,"marketCap":16635152800},{"date":"2025-04-25","current":-15.846935,"twenty":-16.770434,"median":-15.576033,"eighty":-14.349556,"marketCap":17719522633},{"date":"2025-05-02","current":-16.438538,"twenty":-16.715855,"median":-16.124153,"eighty":-14.985809,"marketCap":18420101638},{"date":"2025-05-09","current":-15.074661,"twenty":-16.551291,"median":-15.826729,"eighty":-15.074661,"marketCap":17010399982},{"date":"2025-05-16","current":-15.043786,"twenty":-16.438538,"median":-15.220044,"eighty":-14.405796,"marketCap":17114249721},{"date":"2025-05-23","current":-16.495727,"twenty":-16.438538,"median":-15.262587,"eighty":-14.582474,"marketCap":18822153243},{"date":"2025-05-30","current":-16.208434,"twenty":-16.401371,"median":-15.460562,"eighty":-14.726132,"marketCap":18575651704},{"date":"2025-06-06","current":-16.427701,"twenty":-16.438538,"median":-15.666395,"eighty":-14.905978,"marketCap":18874975001},{"date":"2025-06-13","current":-20.940103,"twenty":-16.693343,"median":-15.893657,"eighty":-15.005253,"marketCap":24069114577},{"date":"2025-06-20","current":-18.479443,"twenty":-18.428819,"median":-16.104695,"eighty":-15.043786,"marketCap":21199132371},{"date":"2025-06-27","current":-18.0452,"twenty":-18.863356,"median":-16.282988,"eighty":-15.074661,"marketCap":20758951051},{"date":"2025-07-04","current":-21.227749,"twenty":-18.942282,"median":-16.427701,"eighty":-15.074735,"marketCap":24421259633},{"date":"2025-07-11","current":-22.045806,"twenty":-19.683704,"median":-16.508309,"eighty":-15.190609,"marketCap":25336836779},{"date":"2025-07-18","current":-25.758166,"twenty":-20.839221,"median":-16.693343,"eighty":-15.21995,"marketCap":29580184704},{"date":"2025-07-25","current":-25.970367,"twenty":-21.539184,"median":-16.981252,"eighty":-15.260218,"marketCap":29932329760},{"date":"2025-08-01","current":-24.963588,"twenty":-22.267132,"median":-18.096065,"eighty":-15.298157,"marketCap":28594178547},{"date":"2025-08-08","current":-27.998627,"twenty":-24.402884,"median":-18.454131,"eighty":-15.429476,"marketCap":32150843612},{"date":"2025-08-15","current":-27.487815,"twenty":-25.397092,"median":-18.863356,"eighty":-15.513126,"marketCap":31516982512},{"date":"2025-08-22","current":-26.341915,"twenty":-25.761111,"median":-19.052333,"eighty":-15.750472,"marketCap":30108402288},{"date":"2025-08-29","current":-8.977182,"twenty":-25.761111,"median":-19.118727,"eighty":-15.513126,"marketCap":27784244918},{"date":"2025-09-05","current":-10.341403,"twenty":-25.547361,"median":-18.897362,"eighty":-15.21995,"marketCap":31974771084},{"date":"2025-09-12","current":-12.806892,"twenty":-25.484142,"median":-18.479443,"eighty":-15.036079,"marketCap":39669140558},{"date":"2025-09-19","current":-11.291493,"twenty":-25.397092,"median":-18.151913,"eighty":-14.569138,"marketCap":34950396808},{"date":"2025-09-26","current":-9.575685,"twenty":-25.265241,"median":-17.183112,"eighty":-14.242848,"marketCap":29562577451},{"date":"2025-10-03","current":-9.769092,"twenty":-25.225948,"median":-16.756996,"eighty":-13.467837,"marketCap":30231653057},{"date":"2025-10-10","current":-8.39875,"twenty":-25.201143,"median":-16.551291,"eighty":-12.508489,"marketCap":25953090627},{"date":"2025-10-17","current":-9.52866,"twenty":-25.090759,"median":-16.467132,"eighty":-11.127698,"marketCap":29421719428},{"date":"2025-10-24","current":-8.24833,"twenty":-24.683236,"median":-16.401371,"eighty":-10.383008,"marketCap":25477694801},{"date":"2025-10-31","current":-8.936138,"twenty":-24.228898,"median":-16.208434,"eighty":-10.01166,"marketCap":27643386896},{"date":"2025-11-07","current":-8.115895,"twenty":-24.0933,"median":-15.983588,"eighty":-9.661913,"marketCap":25090335240},{"date":"2025-11-14","current":-9.615008,"twenty":-24.036348,"median":-15.846935,"eighty":-9.533336,"marketCap":29809078990},{"date":"2025-11-21","current":-8.88084,"twenty":-23.659864,"median":-15.493415,"eighty":-9.411746,"marketCap":27520136126},{"date":"2025-11-28","current":-9.805814,"twenty":-23.032171,"median":-15.270261,"eighty":-9.358381,"marketCap":30496838785},{"date":"2025-12-05","current":-9.522579,"twenty":-22.810207,"median":-15.147164,"eighty":-9.358381,"marketCap":29666872704},{"date":"2025-12-12","current":-9.227769,"twenty":-22.078047,"median":-15.043786,"eighty":-9.232281,"marketCap":28801588916},{"date":"2025-12-19","current":-9.562517,"twenty":-22.024358,"median":-14.816055,"eighty":-9.195431,"marketCap":29916743432},{"date":"2025-12-24","current":-8.86445,"twenty":-21.960012,"median":-14.582474,"eighty":-9.185632,"marketCap":27819193982},{"date":"2026-01-02","current":-8.361415,"twenty":-21.780535,"median":-14.405796,"eighty":-9.071858,"marketCap":26343799029},{"date":"2026-01-09","current":-10.158481,"twenty":-21.573184,"median":-14.143758,"eighty":-9.138635,"marketCap":32085396254},{"date":"2026-01-16","current":-10.130227,"twenty":-21.338723,"median":-13.671075,"eighty":-9.159542,"marketCap":32100133626},{"date":"2026-01-23","current":-9.450777,"twenty":-21.128733,"median":-12.833558,"eighty":-9.159542,"marketCap":29918397524},{"date":"2026-01-30","current":-9.27281,"twenty":-20.989151,"median":-11.556174,"eighty":-9.159542,"marketCap":29489203537},{"date":"2026-02-06","current":-8.834279,"twenty":-20.864442,"median":-11.154997,"eighty":-9.026205,"marketCap":28165855410},{"date":"2026-02-13","current":-9.445101,"twenty":-20.730279,"median":-10.443288,"eighty":-9.076015,"marketCap":30286271904},{"date":"2026-02-20","current":-9.824687,"twenty":-20.674464,"median":-10.43817,"eighty":-9.09489,"marketCap":31458062186},{"date":"2026-02-27","current":-8.771359,"twenty":-20.006759,"median":-10.305855,"eighty":-9.047703,"marketCap":28393379910},{"date":"2026-03-06","current":-8.859488,"twenty":-19.896232,"median":-10.18539,"eighty":-8.969972,"marketCap":28447462538},{"date":"2026-03-13","current":-7.555838,"twenty":-19.630572,"median":-10.144354,"eighty":-8.935093,"marketCap":24373237865},{"date":"2026-03-20","current":-7.859442,"twenty":-19.432697,"median":-9.991099,"eighty":-8.867218,"marketCap":25256587462},{"date":"2026-03-27","current":-8.718949,"twenty":-19.118727,"median":-9.951719,"eighty":-8.854358,"marketCap":25617138318},{"date":"2026-04-02","current":-9.880216,"twenty":-19.012497,"median":-9.885599,"eighty":-8.850342,"marketCap":29168564250},{"date":"2026-04-10","current":-9.180446,"twenty":-18.964111,"median":-9.878849,"eighty":-8.85641,"marketCap":27311727342},{"date":"2026-04-17","current":-9.417233,"twenty":-18.904163,"median":-9.820225,"eighty":-8.842311,"marketCap":28027927148},{"date":"2026-04-24","current":-8.878352,"twenty":-18.860571,"median":-9.805814,"eighty":-8.846908,"marketCap":26425587896},{"date":"2026-04-30","current":-8.372511,"twenty":-18.781003,"median":-9.783435,"eighty":-8.82699,"marketCap":24926391864},{"date":"2026-05-08","current":-7.738947,"twenty":-18.469318,"median":-9.736996,"eighty":-8.785939,"marketCap":23120131584},{"date":"2026-05-15","current":-6.609967,"twenty":-18.384608,"median":-9.691452,"eighty":-8.751075,"marketCap":20699742808},{"date":"2026-05-22","current":-6.440114,"twenty":-18.185423,"median":-9.652725,"eighty":-8.708072,"marketCap":20121739519},{"date":"2026-05-29","current":-6.506712,"twenty":-18.096065,"median":-9.620334,"eighty":-8.669056,"marketCap":20400514838}],"updateTime":1780337028579},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09606\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1137514104","title":"Movement Alert｜Duality Biotherapeutics-B Falls 5.59% in Regular Trading, Continued Correction From Highs Despite Recent Positive Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1137514104","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137514104?lang=en_us&edition=fundamental","pubTime":"2026-06-01 11:09","pubTimestamp":1780283369,"startTime":"0","endTime":"0","summary":"On June 1, Duality Biotherapeutics-B fell 5.59% in regular trading, trading at 212.6 HKD/share, with trading volume of HKD 155 million.The stock has now retreated approximately 60% from its September...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146652648","title":"Movement Alert｜Duality Biotherapeutics-B Rises 5.16% in Regular Trading, ASCO Annual Meeting Opens as ADC Pipeline Advances Boost Sector Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1146652648","media":"Market Focus","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146652648?lang=en_us&edition=fundamental","pubTime":"2026-05-29 11:33","pubTimestamp":1780025606,"startTime":"0","endTime":"0","summary":"On May 29, Duality Biotherapeutics-B rose 5.16% in regular trading, trading at HK$219.8/share, with trading volume of approximately HK$110 million.On the news front, the ASCO annual meeting...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116150162","title":"DualityBio trims outstanding shares via HKD 10.18 million buy-back; issues 21,000 new shares from Pre-IPO options","url":"https://stock-news.laohu8.com/highlight/detail?id=1116150162","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116150162?lang=en_us&edition=fundamental","pubTime":"2026-05-28 19:03","pubTimestamp":1779966186,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. (“DualityBio”) disclosed a mix of share repurchases and option exercises that marginally adjusted its capital structure as of 28 May 2026. DualityBio repurchased 47,800...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100053339","title":"DualityBio-B (09606) Spends HK$10.18 Million on Share Buyback on May 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1100053339","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100053339?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:48","pubTimestamp":1779965296,"startTime":"0","endTime":"0","summary":"DualityBio-B (09606) announced that on May 28, 2026, the company utilized HK$10.18 million to repurchase 47,800 shares.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000252152.HKD","HK0000252160.HKD","LU2543165471.USD","HK0000500386.USD","09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638566270","title":"Duality Biotherapeutics files HKEX next-day disclosure return, repurchase at HKD 212.88/share","url":"https://stock-news.laohu8.com/highlight/detail?id=2638566270","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638566270?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:45","pubTimestamp":1779965110,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics repurchased 47,800 ordinary shares on May 28, 2026 for HKD 10.18 million.Buyback price range: HKD 208.4 to HKD 217.6 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Duality Biotherapeutics Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on May 28, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDLc9wsYh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","HK0000252160.HKD","BK1161","HK0000500386.USD","HK0000252152.HKD","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132277106","title":"Movement Alert｜Duality Biotherapeutics-B Falls 5.38% in Regular Trading, Trading at 210.8 HKD","url":"https://stock-news.laohu8.com/highlight/detail?id=1132277106","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132277106?lang=en_us&edition=fundamental","pubTime":"2026-05-28 13:03","pubTimestamp":1779944598,"startTime":"0","endTime":"0","summary":"On May 28, Duality Biotherapeutics-B fell 5.38% in regular trading, trading at 210.8 HKD/share, with trading volume of 68.3979 million HKD.Within the Biotechnology sector where Duality...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132933124","title":"DUALITYBIO-B Surges Over 5% on Global Phase III Trial Milestone for B7-H3 ADC with BioNTech","url":"https://stock-news.laohu8.com/highlight/detail?id=1132933124","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132933124?lang=en_us&edition=fundamental","pubTime":"2026-05-27 15:06","pubTimestamp":1779865584,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) rose more than 5%. At the time of writing, the stock was up 3.14% to HK$222.6, with a turnover of HK$152 million. The catalyst for the move is recent news from the company's...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","09606","BK4231","HK0000252160.HKD","BK4080","VXUS","HK0000252152.HKD","BK1161","ADC","HK0000500386.USD","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151843636","title":"Movement Alert｜Duality Biotherapeutics-B Rises 5.36% in Regular Trading, Buyback Execution and Institutional Accumulation Boost Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=1151843636","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151843636?lang=en_us&edition=fundamental","pubTime":"2026-05-27 13:43","pubTimestamp":1779860636,"startTime":"0","endTime":"0","summary":"On May 27, Duality Biotherapeutics-B rose 5.36% in regular trading, trading at HK$228.2/share, with trading volume of HK$112 million.On the news front, the company executed an open-market share...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182504270","title":"DUALITYBIO-B (09606) Spends HK$6.5144 Million on Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1182504270","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182504270?lang=en_us&edition=fundamental","pubTime":"2026-05-26 22:16","pubTimestamp":1779804976,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) announced that on May 26, 2026, the company repurchased 30,000 shares, spending a total of HK$6.5144 million. The repurchase price per share ranged from HK$216.2 to HK$218.4.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","HK0000252160.HKD","BK1161","LU2543165471.USD","09606","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120438059","title":"LAV Asset Management Boosts Stake in DUALITYBIO-B with 105,000 Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1120438059","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120438059?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:38","pubTimestamp":1779795502,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on May 20, LAV Asset Management (Hong Kong) Limited increased its holding in DUALITYBIO-B (09606) by 105,000 shares. The transaction...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","09606","EWH","BK1161","HK0000252152.HKD","LU2543165471.USD","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636894779","title":"Duality Biotherapeutics Launches $40 Million Stock Buyback; Shares Rise 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636894779","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636894779?lang=en_us&edition=fundamental","pubTime":"2026-05-20 11:12","pubTimestamp":1779246731,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics  announced plans to buy back up to $40 million worth of its shares from the open market, according to a Tuesday filing with the Hong Kong bourse.The biopharmaceutical firm's shares gained over 3% in morning trade on Wednesday.The company said its current share price does not reflect its intrinsic value, representing a good opportunity to conduct the buyback.Meanwhile, Duality Bio Chairman and Chief Executive Officer Zhu Zhongyuan plans to increase his shareholding in the company by spending up to $5 million to buy shares in the secondary market.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HK0000252152.HKD","BK1161","09606","HK0000252160.HKD","LU2543165471.USD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117028827","title":"DualityBio-B Surges Nearly 5% in Morning Trading, Announces Up to $40 Million Share Buyback Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1117028827","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117028827?lang=en_us&edition=fundamental","pubTime":"2026-05-20 10:00","pubTimestamp":1779242437,"startTime":"0","endTime":"0","summary":"DualityBio-B (09606) saw its stock price rise over 6% during the trading session. At the time of reporting, the stock was up 4.83%, trading at HKD 225.80 with a turnover of HKD 97.17 million. On May...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","HK0000500386.USD","HK0000252152.HKD","HK0000252160.HKD","LU2543165471.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152410415","title":"Movement Alert｜Duality Biotherapeutics Rises 5.66% in Regular Trading, Share Buyback Plan Triggers Rebound After Multi-Day Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=1152410415","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152410415?lang=en_us&edition=fundamental","pubTime":"2026-05-20 09:32","pubTimestamp":1779240740,"startTime":"0","endTime":"0","summary":"On May 20, Duality Biotherapeutics rose 5.66% in regular trading, trading at 217.2 HKD/share, with trading volume of 23.78 million HKD. The stock rebounded after falling from approximately 257 HKD to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112436808","title":"DUALITYBIO-B (09606) Announces Up to $40 Million Share Buyback, Founder Plans Additional $5 Million Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1112436808","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112436808?lang=en_us&edition=fundamental","pubTime":"2026-05-19 22:17","pubTimestamp":1779200266,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) announced that its Board of Directors intends to utilize the general mandate granted by shareholders at the Annual General Meeting held on June 20, 2025, to repurchase the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09606","HK0000500386.USD","LU2543165471.USD","HK0000252160.HKD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636852359","title":"Duality Biotherapeutics Inc - Announces Share Repurchase Plan of up to $40 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2636852359","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636852359?lang=en_us&edition=fundamental","pubTime":"2026-05-19 22:08","pubTimestamp":1779199739,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nFWN41W0AC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000252160.HKD","09606","HK0000252152.HKD","LU2543165471.USD","BK1161","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139994451","title":"DUALITYBIO-B Exercises Option for U.S. Cost and Profit/Loss Sharing on DB-1311/BNT324","url":"https://stock-news.laohu8.com/highlight/detail?id=1139994451","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139994451?lang=en_us&edition=fundamental","pubTime":"2026-05-13 06:38","pubTimestamp":1778625504,"startTime":"0","endTime":"0","summary":"DUALITYBIO-B (09606) announced that on May 12, 2026, Hong Kong Time (the \"Exercise Date\"), the company provided written notice to BioNTech SE (\"BioNTech\"), whose shares are listed on the Nasdaq Stock...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2543165471.USD","HK0000252152.HKD","HK0000500386.USD","BK4588","09606","DB","BK4118","BK4566","HK0000252160.HKD","BK4585","BK4552","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104659656","title":"Duality Biotherapeutics Exercises U.S. Cost- and Profit-Sharing Option for ADC Candidate DB-1311/BNT324 in Collaboration with BioNTech","url":"https://stock-news.laohu8.com/highlight/detail?id=1104659656","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104659656?lang=en_us&edition=fundamental","pubTime":"2026-05-13 06:22","pubTimestamp":1778624576,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. (Duality Biotherapeutics) has formally exercised its exclusive cost and profit/loss sharing option for the antibody-drug conjugate (ADC) DB-1311/BNT324 in the United...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166588783","title":"HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166588783","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166588783?lang=en_us&edition=fundamental","pubTime":"2026-05-11 13:30","pubTimestamp":1778477425,"startTime":"0","endTime":"0","summary":"Biotech stocks jumped in Hong Kong. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"330240692f324d079ccf839d9e4180bf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","03759","02268","03347","02137","02359","06978","09606","09966","02269","09688","09995","06606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103858173","title":"DualityBio-B Adds 0.19 Million New Shares in April; Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1103858173","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103858173?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:03","pubTimestamp":1778151794,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics, Inc. (DualityBio-B) filed its monthly return for the period ended 30 April 2026, highlighting incremental equity issuance driven by option exercises while maintaining...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631513242","title":"Duality Biotherapeutics shareholders approved RMB share issue plan at EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2631513242","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631513242?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:32","pubTimestamp":1777462356,"startTime":"0","endTime":"0","summary":"Duality Biotherapeutics held an extraordinary general meeting on April 29, 2026, passing all resolutions put to shareholders.Shareholders authorized a proposed RMB Share Issue, granting a specific mandate for the issuance.Board received authority to handle matters relating to RMB Share Issue, including related implementation steps.Shareholders endorsed plans tied to RMB Share Issue, including a three-year RMB share price stabilization plan, a three-year dividend return plan, a plan to address accumulated unrecovered losses, use of proceeds, and measures to mitigate dilution of immediate returns.Meeting adopted new procedural rules for shareholder general meetings and board meetings, approving amendments to articles of association, with effectiveness tied to date of listing of RMB Shares on Sci-Tech Board.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL35HBcs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252152.HKD","HK0000252160.HKD","BK1161","LU2543165471.USD","09606","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":84,"code":"91000000","status":"200"}]}}